Pharmacovigilance in Pneumonia: Drug Safety Across Patient Demographics
Abstract
Pneumonia remains a significant global health concern, contributing to substantial morbidity and mortality across diverse patient populations. While antimicrobial therapy is the cornerstone of treatment, drug safety issues, such as adverse drug reactions (ADRs), antimicrobial resistance, and drug-drug interactions, pose critical challenges for optimal patient outcomes. Pneumonia is commonly treated with strong antibiotics, which can sometimes cause side effects in patients. This review combines hospital findings with research evidence to identify which drugs are more likely to cause adverse reactions. Most reactions were mild and improved with proper monitoring and timely changes in treatment. The study highlights the importance of pharmacovigilance in ensuring safe and effective pneumonia management. Pharmacovigilance plays a pivotal role in monitoring and evaluating these safety concerns, especially in varied demographic groups including children, older adults, immunocompromised individuals, and patients with comorbidities. This study examines post-marketing safety data related to pneumonia therapies, analyzing ADR trends, severity, and causality across demographic subgroups. Preliminary findings highlight age-related differences in susceptibility to ADRs, with elderly patients experiencing a higher incidence of cardiotoxic and nephrotoxic events, while pediatric populations exhibited more hypersensitivity reactions. Socioeconomic factors, polypharmacy, and genetic…
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.